The amount of Type I IFNs negatively correlated with tumor size on days eleven and fourteen, where smaller tumors (i.e., responders) had increased IFNα/β concentration compared to larger tumors (i.e., nonresponders) (Fig. 4J, K). The gene discussed is IFNA1; the disease is neoplasm.